Platinum-resistant Recurrent Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Platinum-resistant Recurrent Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: NR in Chemo-induced Peripheral Neuropathy [Phase 2]
Phase 2 trial update for NR in chemo-induced peripheral neuropathy shows termination with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating albumin-bound docetaxel in combination with bevacizumab for platinum-resistant recurrent ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating apatinib combined with pegylated liposomal doxorubicin (PLD) versus PLD alone for platinum-resistant recurrent ovar…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) [Phase 2]
Phase 2 trial update for a biomarker-driven targeted therapy in platinum-resistant recurrent ovarian cancer (AMBITION).